» Articles » PMID: 27341512

The Immunological Landscape in Necrotising Enterocolitis

Overview
Specialty General Medicine
Date 2016 Jun 25
PMID 27341512
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Necrotising enterocolitis (NEC) is an uncommon, but devastating intestinal inflammatory disease that predominantly affects preterm infants. NEC is sometimes dubbed the spectre of neonatal intensive care units, as its onset is insidiously non-specific, and once the disease manifests, the damage inflicted on the baby's intestine is already disastrous. Subsequent sepsis and multi-organ failure entail a mortality of up to 65%. Development of effective treatments for NEC has stagnated, largely because of our lack of understanding of NEC pathogenesis. It is clear, however, that NEC is driven by a profoundly dysregulated immune system. NEC is associated with local increases in pro-inflammatory mediators, e.g. Toll-like receptor (TLR) 4, nuclear factor-κB, tumour necrosis factor, platelet-activating factor (PAF), interleukin (IL)-18, interferon-gamma, IL-6, IL-8 and IL-1β. Deficiencies in counter-regulatory mechanisms, including IL-1 receptor antagonist (IL-1Ra), TLR9, PAF-acetylhydrolase, transforming growth factor beta (TGF-β)1&2, IL-10 and regulatory T cells likely facilitate a pro-inflammatory milieu in the NEC-afflicted intestine. There is insufficient evidence to conclude a predominance of an adaptive Th1-, Th2- or Th17-response in the disease. Our understanding of the accompanying regulation of systemic immunity remains poor; however, IL-1Ra, IL-6, IL-8 and TGF-β1 show promise as biomarkers. Here, we chart the emerging immunological landscape that underpins NEC by reviewing the involvement and potential clinical implications of innate and adaptive immune mediators and their regulation in NEC.

Citing Articles

A Phosphodiesterase Type-5 (PDE-5) Inhibitor, Sildenafil, Ameliorates the NEC Induced Inflammation.

Ovali M, Oztopuz O, Karaboga I Protein J. 2025; .

PMID: 40056331 DOI: 10.1007/s10930-025-10263-y.


Thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles attenuate experimental necrotizing enterocolitis.

Hwang S, Sung S, Kim Y, Yang M, Koh A, Ahn S Stem Cell Res Ther. 2025; 16(1):101.

PMID: 40022236 PMC: 11871789. DOI: 10.1186/s13287-025-04243-3.


Tailored Combinations of Human Milk Oligosaccharides Modulate the Immune Response in an In Vitro Model of Intestinal Inflammation.

Walsh C, Lane J, Van Sinderen D, Hickey R Biomolecules. 2025; 14(12.

PMID: 39766188 PMC: 11727556. DOI: 10.3390/biom14121481.


CCL3 as a novel biomarker in the diagnosis of necrotizing enterocolitis.

Zeng L, Liu W, Li Y, Song Z, Li H, Yin Y BMC Pediatr. 2024; 24(1):843.

PMID: 39732631 PMC: 11681690. DOI: 10.1186/s12887-024-05307-8.


Sodium formate induces development-dependent intestinal epithelial injury via necroptosis and apoptosis.

Wei J, Tian Y, Guan M, Wei J, Ji Y, Tao G Redox Rep. 2024; 29(1):2433393.

PMID: 39620924 PMC: 11613409. DOI: 10.1080/13510002.2024.2433393.


References
1.
Shiou S, Yu Y, Guo Y, Westerhoff M, Lu L, Petrof E . Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production. J Biol Chem. 2013; 288(48):34757-66. PMC: 3843089. DOI: 10.1074/jbc.M113.503946. View

2.
Blakely M, Lally K, McDonald S, Brown R, Barnhart D, Ricketts R . Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg. 2005; 241(6):984-9. PMC: 1359076. DOI: 10.1097/01.sla.0000164181.67862.7f. View

3.
Ewer A, Al-Salti W, Coney A, Marshall J, Ramani P, Booth I . The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut. 2004; 53(2):207-13. PMC: 1774938. DOI: 10.1136/gut.2003.024521. View

4.
Hintz S, Kendrick D, Stoll B, Vohr B, Fanaroff A, Donovan E . Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005; 115(3):696-703. DOI: 10.1542/peds.2004-0569. View

5.
Yoon J, Park J, Ko K, Lim J, Cheon E, Kim H . Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr. 2014; 57(8):351-6. PMC: 4155179. DOI: 10.3345/kjp.2014.57.8.351. View